Medgold to extend warrants, and issues shares for services
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada, January 12, 2016; Medgold Resources Corp. (TSX-V: MED) announces that management has determined that it is in the best interests of the Company to extend the expiry date of certain previously issued private placement warrants. Accordingly, subject to TSX Venture Exchange acceptance, the Company intends to extend the expiry date of outstanding warrants to purchase up to 9,550,000 common shares at $0.15 per share by one year to February 4, 2017, and outstanding warrants[…]
Medgold Expands Joint Venture with Centerra
Vancouver, Canada, January 11, 2016; Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce that Medgold has expanded its joint venture with Centerra Gold Inc. (“Centerra”) to include its Boticas and Chaves gold exploration licences. The two licences will be added to the existing joint-venture agreement currently covering the Valongo Belt licences. Dan James, President of Medgold, said: “We are very pleased to announce that we’ve amended our joint venture agreement with Centerra to include the Boticas and Chaves licences in Portugal. We’ve enjoyed a good working[…]